EMD-22865

Single-particle
2.7 Å
EMD-22865
3D View Gallery
Deposition: 16/10/2020
Map released: 19/01/2022
Last modified: 29/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-22865
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7kgb summary report (pdf.gz) Map and 7kgb FULL report (pdf.gz)
EMICSS annotations (xml)

CryoEM structure of A2296-methylated Mycobacterium tuberculosis ribosome bound with SEQ-9

EMD-22865

Single-particle
2.7 Å
EMD-22865
3D View Gallery
Deposition: 16/10/2020
Map released: 19/01/2022
Last modified: 29/05/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Sample: A2296-methylated Mycobacterium tuberculosis ribosome bound with SEQ-9
Fitted models: 7kgb

Deposition Authors: Cui Z , Zhang J
Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents.
Zhang J, Lair C, Roubert C, Amaning K, Barrio MB , Benedetti Y, Cui Z , Xing Z, Li X, Franzblau SG , Baurin N, Bordon-Pallier F, Cantalloube C, Sans S, Silve S, Blanc I, Fraisse L, Rak A , Jenner LB, Yusupova G, Yusupov M, Zhang J, Kaneko T, Yang TJ, Fotouhi N, Nuermberger E, Tyagi S, Betoudji F, Upton A, Sacchettini JC, Lagrange S
(2023) Cell
PUBMED: 36827973
DOI: doi:10.1016/j.cell.2023.01.043
ISSN: 1097-4172